Enhance Your Retinal Analysis with OCTAINE: AI-Powered Efficiency.
Streamline OCT scan reviews with MAHAMAIA's innovative platform, delivering rapid, AI-driven insights for neurodegenerative disease biomarker detection.
The Challenge: Is Your Retinal Analysis Holding You Back?
Many healthcare institutions face significant challenges with traditional OCT analysis methods.
Overwhelmed by OCT Data Volume?
Are your specialists spending too much time on laborious manual OCT scan reviews, leading to bottlenecks and delayed insights?
Missing Early Neurodegenerative Signs?
Do you lack the advanced AI tools to consistently detect subtle, early-stage biomarkers of neurodegenerative diseases hidden in complex OCT data?
Inefficient Workflows?
Are outdated processes and a lack of automation slowing down your research cycles or clinical decision-making?
The Cost of Delayed Analysis
Traditional OCT analysis methods can lead to:
- Delayed research findings and publications
- Missed early biomarkers of neurodegenerative diseases
- Inefficient use of specialist time and expertise
- Increased costs and delayed patient care
MAHAMAIA - Pioneering OCT Analysis with OCTAINE.
Transforming OCT analysis with OCTA-ViT technology within the OCTAINE platform.
Introducing MAHAMAIA
MAHAMAIA leverages its OCTA-ViT technology within the OCTAINE platform to provide a cutting-edge, AI-powered solution for hospitals, clinics, and research institutions seeking to transform their retinal OCT analysis. We utilize state-of-the-art Vision Transformer models to deliver speed, precision, and powerful new insights.
Our Mission
Our mission is to advance OCT-based neurodegenerative disease detection for improved patient outcomes, empowering you with efficient, AI-driven tools for earlier and more reliable detection of potential NDD biomarkers, ultimately improving research outcomes and paving the way for better patient care.
Unlock the Power of AI
MAHAMAIA brings advanced AI capabilities to your retinal analysis workflow.
Lightning-Fast Automated OCT Analysis with OCTA-ViT
Drastically reduce manual review time. Our system targets inference times of less than 5 seconds per scan, freeing up your experts for higher-value tasks, and improving accuracy and efficiency in neurodegenerative detection.
- Process hundreds of scans in minutes
- Eliminate analysis bottlenecks
- Parallel processing architecture
Advanced AI-Driven Biomarker Detection
Identify potential NDD-related biomarkers (e.g., patterns indicative of Tau/Amyloid proxies, abnormal thinning) with AI precision that may be missed by the human eye alone.
- Detect subtle early-stage indicators
- Consistent analysis criteria
- Continuously improving AI models
Intuitive Web Platform & Dashboard
Seamlessly upload OCT scans, visualize results (including segmentation and biomarker indicators), and track analysis history through a user-friendly interface. No complex installations required.
- Cloud-based accessibility
- Interactive visualization tools
- Secure data management
Enhanced Data-Driven Insights
Gain deeper understanding from your OCT data, support confident clinical decision-making, and accelerate your research with objective, quantifiable AI-generated metrics, leveraging OCTA-ViT's 3D analysis and uncertainty quantification.
- Comprehensive analytical reports
- Longitudinal tracking capabilities
- Research-ready data export
How MAHAMAIA Works
Our streamlined process makes advanced AI analysis accessible to all users, regardless of technical expertise.
1. Upload Scan
Securely upload your OCT scans using the OCTAINE platform. Our platform accepts standard OCT file formats from major manufacturers, ensuring compatibility with your existing equipment.
2. Analyze
OCTAINE, powered by OCTA-ViT, analyzes the scan rapidly, performing 3D layer segmentation and neurodegenerative disease detection. The advanced Vision Transformer models work in parallel to deliver comprehensive analysis in seconds rather than hours.
3. Visualize & Report
Access comprehensive results, including visual overlays and quantitative data, on your dashboard. Export detailed reports for integration with your existing systems or for sharing with colleagues.
Technology Behind MAHAMAIA
Leveraging OCTA-ViT technology within OCTAINE to transform OCT-based analysis.
OCTA-ViT, a State-of-the-Art 3D Vision Transformer
MAHAMAIA leverages its OCTA-ViT technology, specifically optimized for OCT-based neurodegenerative detection.
Register Token Technology
Advanced Register Token technology enables precise spatial awareness within OCT scans, allowing for accurate layer segmentation and biomarker localization.
Continuous Learning System
Our AI models continuously improve through federated learning techniques, incorporating new insights while maintaining strict patient privacy.
Join Our Exclusive MVP Pilot Program
Be among the first to experience the future of retinal analysis.
Be at the Forefront with OCTAINE
Partner with us to test OCTA-ViT's features for an evolving NDD detection platform. Your feedback will directly influence the development of a transformative tool for NDD research and diagnostics.
Experience the Benefits Firsthand
Evaluate MAHAMAIA within your own workflow with our attractive pilot program pricing.
Shape the Future
Your feedback will directly influence the development of a transformative tool for NDD research and diagnostics.
Priority Access
Get early access to new features and updates before they're widely available.
Pilot Program Timeline
Onboarding (Weeks 1-2)
- Platform access setup
- Training sessions for your team
- Initial system configuration
Implementation (Weeks 3-8)
- Integration with your workflow
- Regular check-ins with our support team
- Performance monitoring and optimization
Evaluation & OCTA-ViT Feedback (Weeks 9-12)
- Comprehensive performance review
- Feedback collection and analysis
- Discussion of long-term partnership options
Transformative Use Cases
Discover how MAHAMAIA can transform retinal analysis across different settings.
Research Institution Applications
MAHAMAIA is designed to help neurodegenerative disease research centers streamline their OCT analysis workflow and uncover new insights from retinal data.
Accelerated OCT Analysis with OCTA-ViT
Our AI-powered platform aims to dramatically reduce the time required for OCT scan analysis, potentially freeing up researchers to focus on higher-value tasks and accelerating research timelines.
Enhanced Neurodegenerative Biomarker Detection
MAHAMAIA's advanced algorithms are designed to identify subtle biomarkers that might be missed in manual review, potentially leading to new discoveries in neurodegenerative disease research.
Streamlined Research Workflow
By automating repetitive analysis tasks, our platform aims to help research teams process larger datasets more efficiently, potentially accelerating publication timelines and research output.
Potential Benefits of OCT with OCTAINE
- Process thousands of historical OCT scans in a fraction of the time
- Identify potential new correlations between retinal biomarkers and cognitive decline
- Reduce specialist analysis time from hours to minutes per scan
- Reduce time and costs in NDD diagnosis